A shortage of funding or not enough healthcare projects?
The author, having worked in pharmaceuticals for several decades, has advised, in confidence, both investors and small to medium-sized enterprises on transitioning healthcare research projects into commercial development, mainly in Europe. He is now semi-retired. This note is written in the hope tha...
Saved in:
| Published in | Precision nanomedicine Vol. 7; no. 3 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | English |
| Published |
Andover House Inc
26.09.2024
|
| Online Access | Get full text |
Cover
Loading…
| Summary: | The author, having worked in pharmaceuticals for several decades, has advised, in confidence, both investors and small to medium-sized enterprises on transitioning healthcare research projects into commercial development, mainly in Europe. He is now semi-retired. This note is written in the hope that his experience will improve the success of small and medium-sized enter-prises in their attempts to get non-academic investment funding and make life easier for investors. Whilst focused on drugs, the broader advice is relevant to other healthcare areas, such as diagnostics and devices. |
|---|---|
| ISSN: | 2639-9431 2639-9431 |
| DOI: | 10.33218/001c.124008 |